Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.

Navarini AA, Hruz P, Berger CT, Hou TZ, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg Sgier BC, Kämpe O, Burgener AV, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker LT, Heijnen I, Daikeler TD, Gebbers JO, Grimbacher B, Sansom DM, Jeker R, Hess C, Recher M

J. Allergy Clin. Immunol. 139 (3) 1043-1046.e5 [2017-03-00; online 2016-11-28]

PubMed 27908448

DOI 10.1016/j.jaci.2016.08.042

Crossref 10.1016/j.jaci.2016.08.042

pii: S0091-6749(16)31127-7


Publications 9.5.1